Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (293)	2/14/2003 11:18:51 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

TGEN After making a triple bottom on its hourly chart at the 0.26 level(and a 52wks.L ) on Feb.4, the stock repeated the same action yesterday at the 0.25 level. <g> Early today it announced an European deal with Crucell N.V. (TGEN received a non-exclusive license to use PER.C6 for research and development in the field of vaccines.) The shares have been selling around 0.6 of sales and TGEN has enough cash to go for 3 more Qs at its present "burn rate" without additional financing.<g> The insiders hold more than 40% of the shares. The stocks needs to close above its January 29 H of 0.32 siliconinvestor.com After going over that hurdle, if it can get to test its Dec.10 H at 0.60 it would be a good % gain from present levels.(The Novemeber H looks somewhat too far at present, and TGEN would need "very good news" at the earnings report this month in order to test it.)<g> siliconinvestor.com From a longer term perspective it seems the stock will need some help. Will see if the insiders that hold 40% of the shares can provide it or if they will abandon ship.<g> siliconinvestor.com Bernard